Biofac A/S
Public limited companyCVR 62550511KastrupActive
Biofac A/S is a public limited company, based in Kastrup, active in manufacture of basic pharmaceutical products, founded in 1934. The company went from a profit in 2024 to a loss of DKK 3.8m in 2025. Measured by gross profit, it ranks no. 3 of 14 companies in the industry in the database. With 83 employees, the company is about 4 times larger than the industry median.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 12% (2024 → 2025), to DKK 73.6m.
- Net profit went from a profit of DKK 333k to a loss of DKK 3.8m (2024 → 2025).
- Equity fell 26% (2024 → 2025), to DKK 10.8m.
Employees
- 1 more employees than a year earlier: 83 (07/2026) against 82 (07/2025).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 23,387 | 28,824 | 20,289 | 37,268 | 65,665 | 73,647 | +12.2% |
| Operating profit (EBIT) | −4,204 | 366 | −6,279 | 6,465 | 5,180 | −436 | −108.4% |
| Profit before tax | −5,376 | −1,418 | −7,604 | 2,063 | 430 | −4,623 | −1,174.2% |
| Net profit | −4,193 | −1,135 | −5,953 | 1,610 | 333 | −3,776 | −1,235.5% |
| Total assets | 164,460 | 161,491 | 142,566 | 156,736 | 161,331 | 151,156 | −6.3% |
| Equity | 19,732 | 18,597 | 12,644 | 14,254 | 14,586 | 10,810 | −25.9% |
| Liabilities | 140,407 | 137,348 | 125,609 | 137,785 | 142,018 | 136,897 | −3.6% |
| Cash and cash equivalents | 667 | 52 | 2,127 | 12 | 978 | 249 | −74.5% |
| Average number of employees | 76 | 73 | 75 | – | 74 | 77 | +4.1% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLow equity ratio
Equity makes up 7% of total assets in 2025.
How is this calculated?
Equity ÷ total assets is below 10% in the latest annual report. Banks, insurers and some industries naturally have a low ratio.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/07/2024 – 30/06/2025 | 15/12/2025 | The company | PDF not statedXBRL |
| 2024 | 01/07/2023 – 30/06/2024 | 12/12/2024 | The company | PDFXBRL |
| 2023 | 01/07/2022 – 30/06/2023 | 21/12/2023 | The company | PDFXBRL |
| 2022 | 01/07/2021 – 30/06/2022 | 05/12/2022 | The company | PDFXBRL |
| 2021 | 01/07/2020 – 30/06/2021 | 08/12/2021 | The company | PDFXBRL |
| 2020 | 01/07/2019 – 30/06/2020 | 07/11/2020 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
14 companies in the databaseComparison with the other companies in manufacture of basic pharmaceutical products based on the latest financial year.
Industry median: gross profit DKK 13.9m, net profit DKK 80,789, equity DKK 10.1m, 19 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 50–199 employees4,467 companies in the comparison | No. 1,072of 4,412 Better than 76% | No. 2,806of 4,466 Better than 37% |
| Companies that are at least 30 years old10,276 companies in the comparison | No. 1,087of 10,152 Better than 89% | No. 4,590of 10,275 Better than 55% |
| All companies of type A/S18,025 companies in the comparison | No. 2,055of 17,786 Better than 88% | No. 8,446of 18,024 Better than 53% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of basic pharmaceutical products- Biofac A/SDKK 73.6m
- Xellia Pharmaceuticals ApSDKK 314.9m
- Glycom Manufacturing A/SDKK 226.3m
- Biofac A/S−DKK 3.8m
- Xellia Pharmaceuticals ApSDKK 213.7m
- Glycom Manufacturing A/SDKK 69.2m
- Biofac A/SDKK 10.8m
- Xellia Pharmaceuticals ApSDKK 404.6m
- Glycom Manufacturing A/SDKK 577.7m
- Biofac A/S83
- Xellia Pharmaceuticals ApS458
- Glycom Manufacturing A/S116
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- H&P Rørvig Holding A/S100%
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Peter Rørvig | Director | 17/11/1934 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Peter Rørvig | Board member | 17/11/1934 |
| Niels Ulrik Heine | Board member | 18/02/1998 |
| Helle Rørvig | Board member | 30/11/2005 |
Former management (6)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Erik Vilhelm Balslev | Board member | 17/11/1934 | 18/02/1998 |
| Lore Rørvig | Board member | 17/11/1934 | 22/11/1988 |
| Ludmilla Tamara Dorothea Thiesen | Board member | 17/11/1934 | 22/11/1988 |
| Niels Otto Thiesen | Board member | 17/11/1934 | 08/09/2006 |
| Niels Otto Thiesen | Director | 17/11/1934 | 22/11/1988 |
| Svend Blankholm | Board member | 23/11/2004 | 13/02/2020 |
Signing rule: Selskabet tegnes af 1 direktør eller af 1 bestyrelsesmedlem.
Address and production units
2 active production unitsEnglandsvej 350
2770 Kastrup
Tårnby Municipality · Postcode 2770
Other companies at the address (2)
- A/S Orthana Kemisk FabrikManufacture of basic pharmaceutical products
- Danipharm A/SManufacture of basic pharmaceutical products
| Production unit | Address | Employees | P number |
|---|---|---|---|
| BIOFAC A/S | Englandsvej 350, 2770 Kastrup | 54 | 1003149167 |
| BIOFAC A/S | Ejbyvej 44, 4623 Lille Skensved | 27 | 1003149179 |
Purpose
Selskabets formål er at drive industri og handel eller dermed beslægtet virksomhed efter bestyrelsens skøn såvel i ind- som i udland
The purpose is quoted from the register in Danish.
Changes year by year
31 registered events20251 changeaccounts 1
- AccountsAnnual report for 2025 published
20241 changeaccounts 1
- AccountsAnnual report for 2024 published
20231 changeaccounts 1
- AccountsAnnual report for 2023 published
20221 changeaccounts 1
- AccountsAnnual report for 2022 published
20213 changesaccounts 1 · address 2
- AccountsAnnual report for 2021 published
- AddressMoved to Englandsvej 350-356, 2770 Kastrup
- AddressMoved to Englandsvej 350-356, 2770 Kastrup
20202 changesaccounts 1 · management 1
- AccountsAnnual report for 2020 published
- ManagementSvend Blankholm stepped down as board member
20171 changeaddress 1
- AddressMoved to Englandsvej 350-356, 2770 Kastrup
20061 changemanagement 1
- ManagementNiels Otto Thiesen stepped down as board member
20052 changesmanagement 1 · ownership 1
- ManagementHelle Rørvig appointed board member
- OwnershipH&P Rørvig Holding A/S registered as owner (100%)
20041 changemanagement 1
- ManagementSvend Blankholm appointed board member
19983 changescapital 1 · management 2
- CapitalShare capital changed from 500,000 DKK to 1,000,000 DKK
- ManagementNiels Ulrik Heine appointed board member
- ManagementErik Vilhelm Balslev stepped down as board member
19961 changecapital 1
- CapitalShare capital changed from 400,000 DKK to 500,000 DKK
19911 changemerger 1
- MergerMerger registered in CVR
19883 changesmanagement 3
- ManagementNiels Otto Thiesen stepped down as director
- ManagementLudmilla Tamara Dorothea Thiesen stepped down as board member
- ManagementLore Rørvig stepped down as board member
19871 changemerger 1
- MergerMerger registered in CVR
19348 changesfounded 1 · management 7
- FoundedRegistered as BIOFAC A/S
- ManagementNiels Otto Thiesen appointed board member
- ManagementNiels Otto Thiesen appointed director
- ManagementErik Vilhelm Balslev appointed board member
- ManagementPeter Rørvig appointed board member
- ManagementPeter Rørvig appointed director
- ManagementLudmilla Tamara Dorothea Thiesen appointed board member
- ManagementLore Rørvig appointed board member
Related companies
Same people in management
- Biltema Danmark A/Svia Niels Ulrik Heine
- Ditobus Linjetrafik A/Svia Niels Ulrik Heine
- Trustpilot A/Svia Niels Otto Thiesen
- Pa Consulting Group A/Svia Svend Blankholm
- Ditobus Servicetrafik A/Svia Niels Ulrik Heine
- Ditobus Excursions A/Svia Niels Ulrik Heine
Largest in the industry
- Xellia Pharmaceuticals ApSDKK 314.9m
- Glycom Manufacturing A/SDKK 226.3m
- Zpd A/SDKK 52.7m
- Danipharm A/SDKK 37.6m
- Pharma Medico ApSDKK 32.3m
- A/S Orthana Kemisk FabrikDKK 20.9m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.